KPMG's New Report: 'Psychedelic Drugs: A Market Poised For Takeoff' Exudes Promise For The Industry

The multinational company KPMG, part of the main group of internationally-expanded enterprises offering audit, assurance, taxation, management consulting, actuarial, corporate finance and legal services, has just issued a special report directed to big pharma companies regarding psychedelics for medical purposes. 

The fact that one of the Big Four companies dedicates even a small release on the beneficial impact of psychedelics on health should be seen as a step forward in validating this industry’s potential growth and future projection to major, more …

Full story available on Benzinga.com

More KPMG's New Report: 'Psychedelic Drugs: A Market Poised For Takeoff' Exudes Promise For The Industry